These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32871229)

  • 21. Systematic Comparison of High-throughput Single-Cell and Single-Nucleus Transcriptomes during Cardiomyocyte Differentiation.
    Selewa A; Dohn R; Eckart H; Lozano S; Xie B; Gauchat E; Elorbany R; Rhodes K; Burnett J; Gilad Y; Pott S; Basu A
    Sci Rep; 2020 Jan; 10(1):1535. PubMed ID: 32001747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell RNA sequencing analysis to characterize cells and gene expression landscapes in atrial septal defect.
    Wang Z; Wang H; Zhang Y; Yu F; Yu L; Zhang C
    J Cell Mol Med; 2021 Oct; 25(20):9660-9673. PubMed ID: 34514716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis.
    Zhang H; Tian L; Shen M; Tu C; Wu H; Gu M; Paik DT; Wu JC
    Circ Res; 2019 Aug; 125(5):552-566. PubMed ID: 31288631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype.
    Onódi Z; Visnovitz T; Kiss B; Hambalkó S; Koncz A; Ágg B; Váradi B; Tóth VÉ; Nagy RN; Gergely TG; Gergő D; Makkos A; Pelyhe C; Varga N; Reé D; Apáti Á; Leszek P; Kovács T; Nagy N; Ferdinandy P; Buzás EI; Görbe A; Giricz Z; Varga ZV
    J Mol Cell Cardiol; 2022 Apr; 165():19-30. PubMed ID: 34959166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
    J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
    Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
    Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes.
    Lei W; Feng T; Fang X; Yu Y; Yang J; Zhao ZA; Liu J; Shen Z; Deng W; Hu S
    Stem Cell Res Ther; 2018 Mar; 9(1):56. PubMed ID: 29523209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells.
    Schweizer PA; Darche FF; Ullrich ND; Geschwill P; Greber B; Rivinius R; Seyler C; Müller-Decker K; Draguhn A; Utikal J; Koenen M; Katus HA; Thomas D
    Stem Cell Res Ther; 2017 Oct; 8(1):229. PubMed ID: 29037217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells.
    Fuerstenau-Sharp M; Zimmermann ME; Stark K; Jentsch N; Klingenstein M; Drzymalski M; Wagner S; Maier LS; Hehr U; Baessler A; Fischer M; Hengstenberg C
    PLoS One; 2015; 10(5):e0126596. PubMed ID: 25970162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
    Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
    J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive human stem cell differentiation in a 2D and 3D mode to cardiomyocytes for long-term cultivation and multiparametric monitoring on a multimodal microelectrode array setup.
    Fleischer S; Jahnke HG; Fritsche E; Girard M; Robitzki AA
    Biosens Bioelectron; 2019 Feb; 126():624-631. PubMed ID: 30508787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping.
    Gunawan MG; Sangha SS; Shafaattalab S; Lin E; Heims-Waldron DA; Bezzerides VJ; Laksman Z; Tibbits GF
    Stem Cells Transl Med; 2021 Jan; 10(1):68-82. PubMed ID: 32927497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell sequencing reveals lineage-specific dynamic genetic regulation of gene expression during human cardiomyocyte differentiation.
    Elorbany R; Popp JM; Rhodes K; Strober BJ; Barr K; Qi G; Gilad Y; Battle A
    PLoS Genet; 2022 Jan; 18(1):e1009666. PubMed ID: 35061661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression dynamics of HAND1/2 in in vitro human cardiomyocyte differentiation.
    Okubo C; Narita M; Inagaki A; Nishikawa M; Hotta A; Yamanaka S; Yoshida Y
    Stem Cell Reports; 2021 Aug; 16(8):1906-1922. PubMed ID: 34297940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
    Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
    Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.
    Gai H; Leung EL; Costantino PD; Aguila JR; Nguyen DM; Fink LM; Ward DC; Ma Y
    Cell Biol Int; 2009 Nov; 33(11):1184-93. PubMed ID: 19729070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The generation of a lactate-rich environment stimulates cell cycle progression and modulates gene expression on neonatal and hiPSC-derived cardiomyocytes.
    Ordoño J; Pérez-Amodio S; Ball K; Aguirre A; Engel E
    Biomater Adv; 2022 Aug; 139():213035. PubMed ID: 35907761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental changes in electrophysiological characteristics of human-induced pluripotent stem cell-derived cardiomyocytes.
    Ben-Ari M; Naor S; Zeevi-Levin N; Schick R; Ben Jehuda R; Reiter I; Raveh A; Grijnevitch I; Barak O; Rosen MR; Weissman A; Binah O
    Heart Rhythm; 2016 Dec; 13(12):2379-2387. PubMed ID: 27639456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.